- Inaugural Chair of the Department of Biomedical Data Science
- Founding Director of the Stanford Center for Computational, Evolutionary, and Human Genomics
- Stanford University
For the past 15 years, Dr. Carlos Bustamante has led a multidisciplinary team working on problems at the interface of computational and biological sciences. Much of his research has focused on genomics technology and its application in medicine, agriculture, and evolutionary biology. His first academic appointment was at Cornell University’s College of Agriculture and Life Sciences. There, much of his work focused on population genetics and agricultural genomics motivated by a desire to improve the foods we eat and the lives of the animals upon which we depend. He moved to Stanford in 2010, to focus on enabling clinical and medical genomics on a global scale. He has been particularly focused on reducing health disparities in genomics by: (1) calling attention to the problem raised by >95% of participants in large-scale studies being of European descent; and (2) broadening representation of understudied groups, particularly U.S. minority populations and those from Latin America. Taken together, this work has empowered decision-makers to utilize genomics and data science in the service of improving human health and wellbeing. His future goal is to scale these operations from focusing on researchers to consumers and patients, where we ultimately want our work to have the greatest impact.
Dr. Bustamante also has a strong interest in building new academic units, non-profits, and companies. He is the Inaugural Chair of the Department of Biomedical Data Science, the first new department that Stanford has started in 14 years. He is Founding Director (with Marc Feldman) of the Stanford Center for Computational, Evolutionary, and Human Genomics and former Founding Associate Director of the Cornell Center for Comparative and Population Genomics (3CPG). He serves as an advisor to the US federal government, private companies, startups, and non-profits in the areas of computational genomics, population and medical genetics, and veterinary and plant genomics. He is the founder of Arc-Bio (formerly IdentifyGenomics and BigData Bio) and current chair of it’s Scientific Advisory Board as well as an SAB member of multiple companies listed below. Finally he is the Owner and President of CDB Consulting, LTD., an expert witness, IP, and strategy consulting group.
- Assistant Professor and Associate Director of Bioethics Research
- Center for Translational Bioethics & Health Care Policy
- Geisinger Health System
Jennifer K. Wagner, J.D., Ph.D., is Assistant Professor and Associate Director of Bioethics Research in the Center for Translational Bioethics & Health Care Policy at Geisinger Health System (Danville, PA, USA) and is a licensed, practicing attorney in Pennsylvania. She earned her J.D. at the University of North Carolina in 2007 and her Ph.D. in Anthropology at the Pennsylvania State University in 2010 before completing post-doctoral research appointments at Duke University’s Institute for Genome Sciences & Policy and the University of Pennsylvania’s Center for the Integration of Genetic Healthcare Technologies. She has a K99/R00 NIH "Pathway to Independence Award" from the National Human Genome Research Institute. Prior to joining Geisinger, Dr. Wagner served in a U.S. Senator’s office in Washington, DC as a 2014-2015 AAAS Science & Technology Policy Congressional Fellow, where she managed the judiciary portfolio and assisted with privacy, health, consumer protection, and environmental policy. She is a contributing editor to the Genomics Law Report, member of the ASHG Social Issues Committee, co-chair of the Ethics Committee for the American Association of Physical Anthropologists, and member of the Ethics Committee for the American Association of Anthropological Genetics. Dr. Wagner is on Twitter @DNAlawyer.